trending Market Intelligence /marketintelligence/en/news-insights/trending/gwGpD4YsXbQgu4RKz0q1NA2 content esgSubNav
In This List

Sanofi to pay €3M after Evotec reaches milestone in diabetes collaboration

Case Study

Identifying PPE Suppliers During the Pandemic

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective


Sanofi to pay €3M after Evotec reaches milestone in diabetes collaboration

Evotec AG reached its first milestone under a diabetes alliance with Sanofi, triggering a €3 million milestone payment for achieving preclinical proof of concept.

The collaboration between the two companies, signed in August 2015, aims to develop a therapy based on the functional beta cells derived from human stem cells, Evotec said in a news release.